March 1, 2018 / 1:46 PM / 4 months ago

BRIEF-Vaxil‍ Obtains U.S. Patent For Signal Peptide Antibody Platform

* VAXIL BIO LTD - ‍ OBTAINED A U.S. PATENT FOR ITS SIGNAL PEPTIDE ANTIBODY PLATFORM KNOWN AS SPMAB​

* VAXIL BIO LTD - ‍ SAEID BABAEI HAS RESIGNED FROM HIS ROLE AS CHAIRMAN OF BOARD​

* VAXIL BIO LTD - ‍ISAAC MARESKY HAS ACCEPTED ROLE OF CHAIRMAN FOR TIME BEING​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below